I believe that OWCP may be down right now because many

New Post Public Reply Private Reply Replies (1) Message Board
GaryM
695
I believe that OWCP may be down right now because many investor's feel like I do, which is questioning, in the back of their mind, if OWCP can sell product as a cosmetic without doing efficacy trials in people. Yes, we all know they've done laboratory trials very successfully, and they're doing an FDA accepted safety trial, but to our knowledge, people living with psoriasis are yet to try the product.

This of course may not be true, a couple weeks ago an investor stopped by the company in Israel and was permitted to smear on some of the cream, for all we know the same has occurred with people who had psoriasis. The point I'm making is we don't know that, and we do know it hasn't been done in a double blinded study that meets the criteria of the FDA or other agency to be considered a clinical trial.

I believe that OWCP does know what they're doing, they know many other products of a similar nature are in stores everywhere, the question in my mind, and perhaps many of yours, is will some govt. agency balk at such a product which relies on cannabis to be effective. I believe this doubt could be there until we either see some declaration from the Govt. or are able to go into a Green Cross store and see the cream available for sale there.

Note, I didn't say buy it there because I believe that to do so, people will need a prescription that permits them to purchase at the store.

If the company is correct, it will only be about 3 months before this comes true, if they're completely on schedule. Of course their could be delays in the U.S., but if they're selling it elsewhere, I believe Investor's will be comfortable with what the company has said. The only way of a serious delay occurring here would be if every country said, we require clinical trials for efficacy before the product can be sold.

It's been said that physicians follow the guidelines of first, do no harm. Our Psoriasis Cream will meet that criteria when safety trials prove it safe. It has been shown to work in labs, and it wouldn't surprise me if the company did let people with psoriasis try it, but they cannot say so as it wasn't done in a clinical trial, and it may have been illegal to do so.

Once the cream is on the market, we should get all sorts of anecdotal feedback on whether it's benefiting patients, or not. I don't know how the companies distributing it intend to market it, but one tact that could be considered is a money back guarantee if it fails to work.

Clearly, if all the doubts in the back of our minds are overcome by the company's action, the stock will be dramatically higher, and we'll be very pleased. While I believe the result could be the same if one of our doubts come to pass, but if it did, that success could take much longer, and we could be burdened with lower prices, and dilution, to make that future success happen. I believe the company can do what it's planning to do without delay, but I cannot say it's absolutely certain. Anyone certain about any stock should be so wealthy that they wouldn't be participating here. It would be rather like going to a horse race and knowing all the winners, or playing craps and knowing the number being rolled before the dice was rolled. I don't believe this is as much a gamble as being at the race track or crap table, but any stock can go up, or down.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 94

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
Boardwalk Welcomes New CFO: What This Means for Growth

Updated Category News Views 77

Boardwalk's Leadership Shift: Enter Scott Wexler Nothing spices up a pipeline company's menu like a fresh plate of leadership. Boardwalk Pipelines, out in Houston, just handed the keys to their finance dungeon over to Scott Wexler. He's stepping in as the chief financial officer and senior VP of corporate strategic development, an upgrade that got announced today. Packing...

Continue Reading
EzAccounting: Your Q3 IRS Filing Gets a No-Nonsense Tool

Updated Category News Views 19

Taking Tax Deadlines Head-On Tax season's got businesses sweating all over the country, but it doesn't have to be a full-scale panic attack if you've got the right gear. That's where ezAccounting steps in, dishing out a reliable solution to hit those looming IRS Form 941 deadlines without a migraine. By November 2, 2026, companies are looking to dodge the bullet of...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 29

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
LUNGevity's Bold $1M Bet on Lung Cancer Research

Updated Category News Views 24

Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 17

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Navigating Gas-to-AI Power: Challenges & Opportunities

Updated Category News Views 19

Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 67

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
Fed Holds Steady, But CD Rates Climb: Savers' Edge

Updated Category News Views 37

The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...

Continue Reading
Rothera's KPI Swap Approval: A Financial Game Changer

Updated Category News Views 107

Revolutionizing Risk Management with KPI Swaps Boy, if there's one thing that gets my ticker going, it's the buzz of innovation in financial markets. Rothera just landed a CFTC stamp of approval for something that's about to shake up how institutional traders manage risk: Key Performance Indicator (KPI) swaps. And can you believe it? This isn't just another derivative...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Momentum: Accenture's Strong Earnings Impact Stocks

Updated Category News Views 73

Market Overview: U.S. Stock Dynamics U.S. stocks saw a positive trend with the Dow Jones index experiencing a significant rise of over 250 points in recent trading sessions. Index Performance On this day, the Dow Jones Industrial Average rose by 0.63%, concluding at 42,177.28. Similarly, the NASDAQ increased by 0.54% to reach 18,179.88, while the S&P 500 also saw gains of...

Continue Reading
Exploring Technology for Good: Insights from AI Experts

Updated Category News Views 213

Understanding the Concept of Technology for Good Amidst the fast-evolving landscape of artificial intelligence (AI), one individual stands out for their insights into how technology can profoundly benefit humanity. As a member of the UN advisory body on AI, Zhang Linghan, a seasoned professor, presents a comprehensive view on the philosophy of 'technology for good...

Continue Reading
Corporate America Faces Challenges in Women's Workplace Progress

Updated Category News Views 205

Navigating the Future for Women in the Workplace In a rapidly changing world, the dynamics of the workplace continue to evolve, especially for women. The latest insights underline significant potential setbacks in corporate America that could undermine the progress achieved in recent years. Organizations that once championed diversity and inclusion are at a crossroads,...

Continue Reading
Barington Capital Urges Matthews International Shareholders to Act

Updated Category News Views 221

Barington Capital Urges Matthews International Shareholders to Act Barington Capital Group, L.P., an activist investment firm, is taking the initiative to address the governance concerns at Matthews International Corporation. The firm, owning about 2.2% of Matthews' common stock, has sent a compelling message to shareholders, urging them to elect their director nominees...

Continue Reading
Key Insights from Sampo plc's Annual General Meeting Proposals

Updated Category News Views 193

Overview of the Annual General Meeting Proposals Sampo plc has provided essential insights into the proposals for their upcoming Annual General Meeting (AGM), reflecting the company's strategic initiatives for the upcoming financial year. These proposals stem from the Board of Directors and the Audit Committee, aiming to enhance operational efficiency and shareholder...

Continue Reading